<
 
 
 
 
×
>
You are viewing an archived web page, collected at the request of United Nations Educational, Scientific and Cultural Organization (UNESCO) using Archive-It. This page was captured on 05:43:57 Aug 19, 2016, and is part of the UNESCO collection. The information on this web page may be out of date. See All versions of this archived page.
Loading media information hide

 

Latest News From RBM

To see the Decisions, please click here.

Dear Partners and Friends,

After a period of extensive consultation, the RBM Board agreed at its 29th Meeting in December 2015 on a new governance architecture. This included the establishment of a reconstituted Partnership Board, which could take advantage of the tremendous skill, energy and effectiveness of its partners and lead the organization into a new era.

Subsequently, I am delighted to be writing to you as the newly elected Chair of the Roll Back Malaria (RBM) Partnership Board. I had the honor of being elected, together with an exceptional Vice-Chair in Kieran Daly, by the new RBM Partnership Board during their first face to face meeting held in Geneva on 1-2 of June 2016.

It is with humility that I accept the role of Chair at this critical time for the Partnership and for the fight against malaria and I thank the Board members for their confidence. With a new Board, interim supporting structure and an agreed transition strategy we are moving forward with pace, vigor and purpose and I look forward to working together with you all to accelerate efforts to end malaria for good.

Last week’s face to face Board meeting represented a critical milestone for the revitalized Partnership; an opportunity to hear about the formidable work that is continuing to be taken forward by Partners working together to fight malaria across the world, including working together to effectively communicate and advocate on World Malaria Day and the ongoing efforts of the Harmonization Working Group, and discuss how the revitalized Partnership can best support these efforts moving forward. This Board comprises an incredibly experienced and capable group of individuals from across the malaria and development community whose shared and active commitment to the facilitation of effective strategic communication, country and regional support and the mobilization of the necessary resources to achieve malaria elimination, was evident.

A range of important decisions were made at what was an incredibly productive meeting, attended by all new Board membersi. The Board Decision Points are attached to this letter; they include details of our decisions to:

  • Undertake a detailed and rapid review of Partnership Bye-Laws to ensure they reflect the Partnerships new structures and governance arrangements agreed at its 29th Meeting in December 2015;
  • Commence negotiations with UNOPS as the most appropriate host for the Partnership following the detailed assessment and consideration of a range of options;
  • Assume responsibility for un-earmarked RBM funds held at WHO through the Chair on behalf of RBM;
  • Approve the plan to establish and take forward the new Partnership structures, to be coordinated by an Interim Support Team (IST), including the next phase of the country / regional consultation and engagement process (in collaboration with regional leadership, platforms and structures), the finalization of the governance and hosting arrangements, set up and support for the new Partner Committees and recruitment of a permanent management team; and
  • Recognize the ongoing work of Partners collaborating to advance priority areas of work including the importance of the ongoing work of the Harmonization Working Group core functions.

To see the Decisions, please click here.

We also reviewed the role of an emerging global high-level leadership initiative, the ‘End Malaria Council’, agreeing on its importance and potential in helping raise the profile, support and resources for the fight against malaria. We look forward to working with them going forward.

I would also like to take this opportunity, in my first communication as Board Chair, to express my sincere thanks and appreciation to my predecessor the Honorable Victor Makwenge Kaput, and to all the members of the former Roll Back Malaria Partnership Board including the Transition Oversight Committee (TOC) Co-Chairs Adm. Tim Ziemer and the Honorable Minister David Parirenyatwa and the Secretariat Staff; and the WHO for their excellent commitment and contribution to the Partnership and in getting us to this pivotal moment.

It is an incredibly exciting time for RBM and I look forward to working with Partners to build on our successes and move forward with purpose to achieve our vision of a malaria free world.

Yours sincerely,
Dr. Winnie Mpanju-Shumbusho
RBM Partnership Board Chair


        i List of Partnership Board Members

  • Dr Pedro L. Alonso, Director of the WHO Global Malaria Programme
  • Mr Elhadj As Sy, Secretary General, International Federation of Red Cross and Red Crescent Societies
  • Mr Simon Bland, Director – New York Office, UNAIDS
  • Prof Awa Coll-Seck, Minister of Health & Social Welfare, Senegal
  • Mr Kieran Daly, Deputy Director: Global Policy & Advocacy – Malaria, HIV, TB and the Global Fund, Bill & Melinda Gates Foundation
  • Mr Paulo Gomes, Chairman, Paulo Gomes and Partners, former Executive Director, World Bank
  • Dr Richard Nchabi Kamwi, Elimination 8 Ambassador, former Minister of Health, Namibia
  • Dr Altaf Lal, Senior Advisor on Global Health and Innovation, Sun Pharmaceuticals Industries
  • Dr Winnie Mpanju-Shumbusho, former Assistant Director General - Malaria, HIV, TB, NTDs, WHO
  • Mr Ray Nishimoto, President of Health & Crop Sciences Sector, Sumitomo Chemical
  • Dr David Reddy, Chief Executive, Medicines for Malaria Venture
  • HE Yongyuth Yuthavong, former Deputy Prime Minister and former Minister of Science and Technology
  • Rear Admiral Tim Ziemer USN (ret), Global Co-ordinator, US President's Malaria Initiative

After a two-year period of broad consultation and discussion, the RBM Board decided to establish a new, more robust structure that takes advantage of the tremendous skill, energy and effectiveness of its many partners and to move conclusively into a new era that will take action to realize the vision of a world free of malaria.

As part of this new structure, RBM Board decided to launch a process for the establishment of a new Partnership Board. The nominations process for new Board members is now open. Nominations will close on 5 February 2016. The links below provide full details of the nominations process and the related forms for nominating candidates for the new Partnership Board.

[Board Nomination form]
[Board Nomination pack]

The Roll Back Malaria (RBM) Partnership has named a new board to lead the global organization into a new era and drive momentum to end malaria for good.

The intensified, collaborative effort by RBM partners to support affected countries to end malaria is saving millions of lives, increasing attendance at school, improving worker productivity and boosting local economies. But malaria remains a serious public health threat. Eliminating malaria is critical to achieving the Sustainable Development Goals, and must remain a key priority for the global development community.

In the middle of December 2013, the RBM Board commissioned an external evaluation to ensure the Partnership was well positioned to drive continued momentum towards a malaria-free world This evaluation concluded that significant adjustments to RBM’s structure would be necessary to sustain its successes and build on them to deliver on the ambitious goals and objectives of the 2030 WHO Global Technical Strategy (GTS) and accompanying RBM Action and Investment to defeat Malaria (AIM).

After a period of extensive consultation, the RBM Board agreed at its 29th Meeting in December 2015 on a new governance architecture. This included the establishment of a reconstituted Partnership Board, which could take advantage of the tremendous skill, energy and effectiveness of its partners and lead the organization into a new era with a focus on ending malaria. As a result, a transparent public nomination process was announced in January 2016 to identify outstanding new Board members.

The response to the call for nominations was overwhelming: more than 100 nominations were received from the wide malaria and related multi-sectoral community, including government, civil society, non-government organisations, the private sector, donor funding organisations (governmental, multilateral or private philanthropic), and research and academia.

After a robust assessment and selection process 13 individuals have been chosen to take the revitalised Partnership forward, along with an additional Board member to be named by the WHO:

  • Mr Elhadj As Sy, Secretary General, International Federation of Red Cross and Red Crescent Societies
  • Mr Simon Bland, Director – New York Office, UNAIDS
  • Prof Awa Coll-Seck, Minister of Health & Social Welfare, Senegal
  • Mr Kieran Daly, Deputy Director: Global Policy & Advocacy – Malaria, HIV, TB and the Global Fund, Bill & Melinda Gates Foundation
  • Mr Paolo Gomes, Chairman, Paulo Gomes and Partners, former Executive Director, World Bank
  • Dr Richard Nchabi Kamwi, Elimination 8 Ambassador, former Minister of Health, Namibia
  • Dr Altaf Lal, Senior Advisor on Global Health and Innovation, Sun Pharmaceuticals Industries
  • Dr Winnie Mpanju-Shumbusho, former Assistant Director General - Malaria, HIV, TB, NTDs, WHO
  • Mr Ray Nishimoto, President of Health & Crop Sciences Sector, Sumitomo Chemical
  • Dr David Reddy, Chief Executive, Medicines for Malaria Venture
  • Mr Gu Xueming, President of the Chinese Academy of International Trade and Economic Cooperation
  • HE Yongyuth Yuthavong, Deputy Prime Minister, Thailand
  • Rear Admiral Tim Ziemer USN (ret), Global Co-ordinator, US President's Malaria Initiative

This new Partnership Board includes individuals with deep expertise and experience at a senior decision-making level as well as representation from across the Partnership, including malaria-affected countries, private sector, civil society, donor funding organisations, and entities outside the malaria and health sectors, civil society and donors.

In confirming the result of the vote the current Board Chair the Honorable Victor Makwenge Kaput stated that he believed that the individuals selected:

“represented an impressive group of distinctly qualified individuals who will be well-positioned to take the RBM Partnership to a new level in its evolution.”

The new Board are expected to assume responsibility for leading the Partnership from April 2016 and RBM are confident that the changes to the architecture of the Partnership will result in a strengthened malaria partnership well-positioned to support the delivery of the ambitious goal of Ending Malaria for Good.

Transition Support
A new Transition Support Team has been convened by Malaria No More UK in November 2015, to provide additional project management support to the Transition Oversight Committee. They will act as a central point of contact for the Transition over the coming months, providing Transition Management Support to the TOC and, if required, in transitioning to the incoming Board.

This small Transition Support Team is comprised of targeted programme and change management experts, led by Jonah Grunsell from Headadvisory Consulting based in the UK. They have extensive experience in leading transformational change programmes in the public and third sectors. Ian Boulton (TropMed Pharma Consulting) will also bring his insight and expertise from fifteen years of involvement with the fight against malaria and RBM to the team. They can be contacted at ProgTeam@RBMTransition.com.

The Restructuring Q&A has not been fully updated, but further information on the Restructuring Process is now available here.